WAT - Waters Corporation
NYSE
->
Healthcare
->
Diagnostics & Research
Milford,
United States
Type: Equity
WAT price evolution
WAT
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $395.08 | $336.41 | $329.69 | $486.07 |
| Short term investments | $0.9 | $0.9 | $0.89 | $0.89 |
| Net receivables | $702.17 | $631.28 | $693.44 | $683.34 |
| Inventory | $516.24 | $544.4 | $536.83 | $499.42 |
| Total current assets | $1614.38 | $1634.53 | $1681.18 | $1773.7 |
| Long term investments | ||||
| Property, plant & equipment | $639.07 | $701.57 | $707.62 | $676.28 |
| Goodwill & intangible assets | $1934.63 | $1939.24 | $1963.23 | $664.36 |
| Total noncurrent assets | $2873.99 | $2862.65 | $2867.01 | $1533.12 |
| Total investments | $0.9 | $0.9 | $0.89 | $0.89 |
| Total assets | $4626.85 | $4497.18 | $4548.2 | $3306.82 |
| Current liabilities | ||||
| Accounts payable | $84.7 | $79.83 | $81.92 | $93.56 |
| Deferred revenue | $256.68 | $275.94 | $324.67 | $306.87 |
| Short long term debt | $77.83 | $76.53 | $75.91 | $74.51 |
| Total current liabilities | $789.58 | $745.03 | $809.39 | $801.95 |
| Long term debt | $2355.51 | $2515.43 | $2647.05 | $1492.39 |
| Total noncurrent liabilities | $2686.93 | $2846.63 | $2967.58 | $1905.05 |
| Total debt | $2442.26 | $2591.96 | $2722.96 | $1566.9 |
| Total liabilities | $3476.51 | $3591.66 | $3776.97 | $2707 |
| Shareholders' equity | ||||
| Retained earnings | $9150.82 | $8934.62 | $8800.06 | $8649.51 |
| Other shareholder equity | $1150.34 | -$146.3 | -$128.8 | -$132.8 |
| Total shareholder equity | $1150.34 | $905.52 | $771.23 | $599.82 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $395.08 | $480.53 | $501.23 | $436.69 |
| Short term investments | $0.9 | $0.86 | $68.05 | $6.45 |
| Net receivables | $702.17 | $722.89 | $612.65 | $573.32 |
| Inventory | $516.24 | $455.71 | $356.1 | $304.28 |
| Total current assets | $1614.38 | $1659.99 | $1628.94 | $1401.03 |
| Long term investments | ||||
| Property, plant & equipment | $639.07 | $582.22 | $632.65 | $587.25 |
| Goodwill & intangible assets | $1934.63 | $657.73 | $680.27 | $703.01 |
| Total noncurrent assets | $2873.99 | $1517.55 | $1465.99 | $1438.89 |
| Total investments | $0.9 | $0.86 | $68.05 | $6.45 |
| Total assets | $4626.85 | $3281.45 | $3094.93 | $2839.92 |
| Current liabilities | ||||
| Accounts payable | $84.7 | $93.3 | $96.8 | $72.21 |
| Deferred revenue | $256.68 | $227.91 | $227.56 | $198.24 |
| Short long term debt | $77.83 | $76.43 | $27.91 | $177.76 |
| Total current liabilities | $789.58 | $785.74 | $680.51 | $804.98 |
| Long term debt | $2355.51 | $1574.88 | $1573.49 | $1274.71 |
| Total noncurrent liabilities | $2686.93 | $1991.23 | $2046.87 | $1802.79 |
| Total debt | $2442.26 | $1663.41 | $1601.4 | $1452.48 |
| Total liabilities | $3476.51 | $2776.97 | $2727.38 | $2607.78 |
| Shareholders' equity | ||||
| Retained earnings | $9150.82 | $8508.59 | $7800.83 | $7107.99 |
| Other shareholder equity | $1150.34 | $504.49 | -$111.86 | -$117.94 |
| Total shareholder equity | $1150.34 | $504.49 | $367.55 | $232.14 |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $819.47 | $711.69 | $740.58 | $684.67 |
| Cost of revenue | $291.41 | $301.08 | $284.38 | |
| Gross Profit | $501.11 | $420.29 | $439.5 | $400.29 |
| Operating activities | ||||
| Research & development | $41.99 | $45.87 | $42.69 | |
| Selling, general & administrative | $186.75 | $186.95 | $181.96 | |
| Total operating expenses | $236.89 | $240.86 | $239.64 | $226.13 |
| Operating income | $179.43 | $199.86 | $174.17 | |
| Income from continuing operations | ||||
| EBIT | $183.64 | $203.55 | $179.62 | |
| Income tax expense | $21.39 | $18.64 | $29.72 | $24.25 |
| Interest expense | -$26.07 | $30.44 | $23.27 | $14.44 |
| Net income | ||||
| Net income | $216.21 | $134.55 | $150.55 | $140.92 |
| Income (for common shares) | $134.55 | $150.55 | $140.92 | |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2956.42 | $2971.96 | $2365.36 | |
| Cost of revenue | $1248.18 | $1006.69 | ||
| Gross Profit | $1761.19 | $1723.77 | $1358.68 | |
| Operating activities | ||||
| Research & development | $176.19 | $140.78 | ||
| Selling, general & administrative | $658.03 | $553.7 | ||
| Total operating expenses | $943.52 | $850.38 | $714.96 | |
| Operating income | $873.39 | $643.71 | ||
| Income from continuing operations | ||||
| EBIT | $886.64 | $659.98 | ||
| Income tax expense | $94.01 | $130.09 | $89.34 | |
| Interest expense | -$82.24 | $48.8 | $49.07 | |
| Net income | ||||
| Net income | $642.23 | $707.75 | $521.57 | |
| Income (for common shares) | $707.75 | $521.57 | ||
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $134.55 | $150.55 | $140.92 | |
| Operating activities | ||||
| Depreciation | $47.81 | $38.88 | $31.15 | |
| Business acquisitions & disposals | -$1285.91 | |||
| Stock-based compensation | $8.49 | $10.93 | $12.8 | |
| Total cash flows from operations | $157.82 | $18.12 | $196.75 | |
| Investing activities | ||||
| Capital expenditures | -$38.05 | -$46.61 | -$34.39 | |
| Investments | $0.65 | -$0.02 | ||
| Total cash flows from investing | -$1442.27 | -$37.4 | -$1332.51 | -$34.41 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $8.77 | $6.01 | -$67.13 | |
| Net borrowings | -$125.18 | $1149.74 | -$94.96 | |
| Total cash flows from financing | $754.95 | -$113.53 | $1158.17 | -$159.21 |
| Effect of exchange rate | -$0.95 | -$0.17 | -$0.15 | $2.41 |
| Change in cash and equivalents | -$85.45 | $6.72 | -$156.38 | $5.54 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $707.75 | $692.84 | $521.57 | |
| Operating activities | ||||
| Depreciation | $130.42 | $131.68 | $125.36 | |
| Business acquisitions & disposals | -$80.55 | |||
| Stock-based compensation | $42.56 | $29.92 | $36.87 | |
| Total cash flows from operations | $611.66 | $747.27 | $790.51 | |
| Investing activities | ||||
| Capital expenditures | -$175.92 | -$161.27 | -$172.38 | |
| Investments | $75.49 | -$63.36 | -$11.16 | |
| Total cash flows from investing | -$1442.27 | -$107.97 | -$231.63 | -$264.09 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$583.26 | -$593.29 | -$130.38 | |
| Net borrowings | $60 | $151.46 | -$325.37 | |
| Total cash flows from financing | $754.95 | -$509.63 | -$438.27 | -$440.5 |
| Effect of exchange rate | -$0.95 | -$14.77 | -$12.83 | $15.07 |
| Change in cash and equivalents | -$85.45 | -$20.7 | $64.54 | $100.98 |
News
Fundamentals
| Market cap | $17.51B |
|---|---|
| Enterprise value | $19.55B |
| Shares outstanding | 59.13M |
| Revenue | $2.96B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $642.23M |
| Revenue Q/Q | -4.55% |
| Revenue Y/Y | N/A |
| P/E ratio | 27.26 |
|---|---|
| EV/Sales | 6.61 |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 5.92 |
| P/B ratio | InfinityT |
| Book/Share | 0.00 |
| Cash/Share | 6.68 |
| EPS | $10.86 |
|---|---|
| ROA | 15.13% |
| ROE | 74.96% |
| Debt/Equity | 3.02 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.04 |
| Quick ratio | 1.39 |